A. Fleishman
- Hematology top 5%
- Oncology
- Molecular Biology
- Biochemistry top 10%
- Immunology
- Co-authors
- John A. GlaspyJohn C. ReedYiping TuJames BerensonAlan ColowickJudith WeiszJeremy M. G. TaylorAlan Lichtenstein
- Topics
- Erythropoietin and Anemia Treatment (10 papers)Biosimilars and Bioanalytical Methods (4 papers)Pharmacological Effects and Toxicity Studies (2 papers)
- Cited by
- HematologyBiochemistryOncology
- Partner nations
- United StatesAustriaJapan
In The Last Decade
A. Fleishman
15 papers receiving 513 citations
Peers
Comparison fields: 5 of 68
- Hematology 305
- Oncology 181
- Molecular Biology 168
- Biochemistry 82
- Immunology 54
Countries citing papers authored by A. Fleishman
This map shows the geographic impact of A. Fleishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Fleishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Fleishman more than expected).
Fields of papers citing papers by A. Fleishman
This network shows the impact of papers produced by A. Fleishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Fleishman. The network helps show where A. Fleishman may publish in the future.
Co-authorship network of co-authors of A. Fleishman
This figure shows the co-authorship network connecting the top 25 collaborators of A. Fleishman. A scholar is included among the top collaborators of A. Fleishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Fleishman. A. Fleishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 101 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 32 | |
| 11 | 69 | |
| 12 | 69 | |
| 13 | 11 | |
| 14 | 18 | |
| 15 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 201 |
About A. Fleishman
A. Fleishman is a scholar working on Hematology, Biochemistry and Virology, having authored 15 papers that have together received 528 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (10 papers), Biosimilars and Bioanalytical Methods (4 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Hematology (305 citations), Biochemistry (82 citations) and Oncology (181 citations). A. Fleishman has collaborated with scholars based in United States, Austria and Japan. Frequent co-authors include John A. Glaspy, John C. Reed, Yiping Tu, James Berenson, Alan Colowick, Judith Weisz, Jeremy M. G. Taylor, Alan Lichtenstein, Stanisław Krajewski and Matthew B. Rettig. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.